Comparison of Epidemiological Estimates for 19 Cancer Types Using Electronic Health Record Databases in England: An Analysis of CPRD Aurum and CPRD GOLD Databases with Linked Hospital Episode Statistics and Cancer Registry Data
Findings highlight variation in cancer recording across different data sources. Researchers using CPRD data should assess the benefit of incorporating linked data on a study-by-study basis. For studies of breast, prostate, and lung cancers, CPRD Aurum or GOLD alone may be sufficient; however, linkage to HES and/or CR is recommended where a more complete case capture is required.
Authors
- David Neasham (ORCID: https://orcid.org/0000-0002-0270-0372)
- Katrina Wilcox Hagberg (ORCID: https://orcid.org/0000-0002-2407-2995)
- George Kafatos (ORCID: https://orcid.org/0000-0001-7871-9216)
- Andrew Chaplin
- Olia Archangelidi
Institutions
- Boston Collaborative Drug Surveillance Program (US)
- Amgen (United Kingdom) (GB)
Publication Details
- Journal
- Clinical Epidemiology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/clep.s558429
- Citations
- 1
- Primary Topic
- Data-Driven Disease Surveillance
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Gerber Foundation
- Amgen
- BeiGene